Login Register
icon_bulk_orderBulk order Acrobiosystems for English
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Non SARS-Cov-2 Kits > BAFFR > EP-119

BAFFR [Biotinylated] : BAFF Inhibitor Screening ELISA Kit

For research use only.
IDComponentsSize
EP119-C01High-bind Plate1 plate
EP119-C02Human BAFF20 μg
EP119-C03Biotinylated Human BAFFR10 μg
EP119-C04Anti-BAFFR Neutralizing Antibody20 μg
EP119-C05Streptavidin-HRP10 μg
EP119-C06Coating Buffer12 mL
EP119-C0710xWashing Buffer 50 mL
EP119-C08Blocking Buffer50 mL
EP119-C09Substrate Solution24 mL
EP119-C10Stop Solution7 mL
  • Background
    BAFF receptor (B-cell activating factor receptor, BAFF-R), also known as tumor necrosis factor receptor superfamily member 13C (TNFRSF13C), is a membrane protein of the TNF receptor superfamily which recognizes BAFF. B-cell activating factor (BAFF) enhances B-cell survival in vitro and is a regulator of the peripheral B-cell population. Overexpression of BAFF in mice results in mature B-cell hyperplasia and symptoms of systemic lupus erythematosus (SLE). Also, some SLE patients have increased levels of BAFF in serum. Therefore, it has been proposed that abnormally high levels of BAFF may contribute to the pathogenesis of autoimmune diseases by enhancing the survival of autoreactive B cells.
  • Application
    This kit is developed for screening for inhibitors of human BAFFR binding to human BAFF

    It is for research use only.

  • Reconstitution
    Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.
  • Storage
    The unopened kit is stable for 12 months from the date of manufacture if stored at 2°C to 8°C.

    The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • Assay Principles
    This inhibitor screening ELISA kit is designed to facilitate the identification and characterization of new BAFFR pathway inhibitors. The assay takes advantage of our in house-developed binding of biotinylated human BAFFR to immobilized human BAFF in a functional ELISA assay, and employs a simple colorimetric ELISA platform. Briefly, we provide you with a human Biotinlated BAFFR protein, a human BAFF protein, an anti-BAFFR neutralizing antibody (as method verified Std.), and Streptavidin-HRP reagent.

    Your experiment will include 4 simple steps:

    a) Coat the plate with human BAFF.

    b) Add your molecule of interest to the tests.

    c) Add human BAFFR-Biotin to bind the coated human BAFF.

    d) Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.

    Finally, the half maximal inhibitory concentration (IC50) of your compound to BAFFR: BAFF binding will be determined by comparing OD readings among different experimental groups.

Typical Data
 BAFFR ELISA

INHIBITION OF BAFFR [BIOTINYLATED]: BAFF BINDING BY ANTI-BAFFR NEUTRALIZING ANTIBODY
Serial dilutions of Anti-BAFFR Neutralizing antibody (Catalog # EP119-C04) (1:1 serial dilution, from 10 μg/mL to 0.02μg/mL) was added into BAFF: Biotinlated BAFFR binding reactions. The assay was performed according to the protocol described above. Background was subtracted from data points prior to log transformation and curve fitting (QC tested).

Comments (0)


ETD of in-stock products: 2 business days

Price(USD) : $650.00

Licensing

more

Promotion & Exhibitions



Drug Development Status

  • Number of Launched Drugs:0 Details
  • Number of Drugs in Clinical Trials:1 Details
  • Latest Research Phase:Phase 3 Clinical

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Contact Us

+1  800-810-0816 (US)
+86 400-682-2521 (AP)

Related Products

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop
Call us
Call us
North America: +1 800-810-0816 (Toll Free)
Asia & Pacific: +86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message